Keraplast extends wound care distribution network to Turkey
San Antonio, June 20, 2012 (GLOBE NEWSWIRE) -- Keraplast Technologies, LLC the developer of ReplicineTM Functional Keratin®Advanced Wound care products announced today having entered an agreement with Gramatek Ltd, for distribution of their advanced wound care products to Hospitals and wound care centers throughout Turkey. Partnering with Gramatek provides Keraplast access to Hospitals, Clinics and strategic Points of service centers throughout key regional areas of Turkey, said Michael Espensen, CEO of Keraplast Technologies, LLC. "We are extremely pleased to enter into this agreement with such an esteemed organization and to provide members served by Gramatek with our paradigm changing line of Replicine™ Functional Keratin® products. Clinicians in many regions of the world, including the USA, Europe, Australia, New Zealand, South Africa, and now Turkey can utilize the latest clinical advancement in wound healing. The global interest in kerasorb®, keramatrix®, keragel™ and keragelT™ is expanding quickly and were putting in a strong network to provide good support wherever the products are in demand".
CONTACT: Dr. Rob Kelly; Rob.Kelly@keraplast.com; 210-591-8573 William Moore; firstname.lastname@example.org; 210-494-5596
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here